Cell & Gene Therapy World 2018
Event Agenda
A three-day program of strategic partnering, learning, workshops, and networking for senior professionals in advanced therapies.
Program at a glance
The agenda brought together sessions and networking focused on cell and gene therapy, with optional sessions and an I-O Collaboration Lunch included.
Cell & Gene Therapy World 2018 took place from 22–25 January 2018 at the Hyatt Regency, Miami.
Cell and gene therapy represents a transformative frontier in modern medicine, where living cells and genetic material are harnessed to treat, repair, or replace damaged tissues and disease-causing mutations. This rapidly evolving field spans disciplines including immuno-oncology, regenerative medicine, and stem cell research, drawing together scientists, clinicians, and industry leaders. Conferences dedicated to these therapies serve as crucial convergence points where breakthrough discoveries meet commercial development, helping to accelerate the journey from laboratory innovation to patient access across global healthcare systems.
Strategic partnering lies at the heart of any successful cell and gene therapy gathering, creating dedicated spaces where senior executives, investors, and developers can forge meaningful collaborations. Three-day programs typically balance formal learning with structured networking opportunities, allowing attendees to explore manufacturing challenges, supply chain logistics, and market access considerations. The integration of workshops, panel discussions, and one-to-one meeting facilitation ensures that participants leave with both expanded knowledge and concrete business relationships that can drive their pipelines forward.
Optional sessions and specialized forums add tremendous value to therapy-focused conferences by addressing niche topics that warrant deeper exploration. These might include cord blood and perinatal cell applications, bioprocess automation, translational research methods, or immuno-oncology collaboration lunches. Such focused tracks acknowledge that the cell and gene therapy landscape is too vast for any single agenda to cover comprehensively. By offering parallel streams, organizers can accommodate diverse interests ranging from academic research to commercial scale-up, ensuring every attendee finds relevant content aligned with their professional priorities.
The agenda of a well-designed therapy conference reflects the full ecosystem required to bring advanced treatments to patients. From manufacturing and bioprocess engineering to regulatory navigation and investment strategy, each session contributes to a holistic understanding of the industry. Networking events, advisory board meetings, and exhibition halls complement the educational program, while digital tools like personalized planners help attendees navigate complex schedules. This integrated approach transforms a simple conference into a comprehensive platform where global leaders shape the future trajectory of personalized medicine together.
- Strategic partneringThree days of learning and industry connection.
- Optional sessionsAdditional areas for focused discussion and participation.
- I-O Collaboration LunchIncluded as part of the event program.
- Co-located programWorld Stem Cell Summit complemented the conference.